Based on the role of DDR1 in HNSCC in tumor progression and immune escape, we believed that DDR1 could be a promising target for the combined application of CIR, thereby improving the therapeutic effect of HNSCC. Here, DDR1 is linked to head and neck squamous cell carcinoma.